Drug shortage: Atropine Sulfate Injection (ATROPINE SULFATE)
FDA lists 19 presentations as Current. Availability: Unavailable (7), Available (10). Reason: Requirements related to complying with good manufacturing practices; Discontinuation of the manufacture of the drug. Companies: Accord Healthcare Inc., Hikma Pharmaceuticals USA, Inc., Amphastar Pharmaceuticals, Inc., Medefil, Inc., American Regent, Inc.….
- Published by source
- 2012-01-01
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Accord Healthcare Inc.
- Products
- Atropine Sulfate Injection ATROPINE SULFATE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: mid-September 2026
- Estimated recovery: late December 2026/early January 2027
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2012-01-01
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #908 | new | 2026-10-22 | f6c7ed4af4e5…3d6578 | 3c12b63e3541…c46a71 |
Chain head: #1076 8ad5adc30b9b…88ce20